BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 27070462)

  • 21. Che-1 gene silencing induces osteosarcoma cell apoptosis by inhibiting mutant p53 expression.
    Liu M; Wang D; Li N
    Biochem Biophys Res Commun; 2016 Apr; 473(1):168-173. PubMed ID: 27012205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrative genome analysis of somatic p53 mutant osteosarcomas identifies Ets2-dependent regulation of small nucleolar RNAs by mutant p53 protein.
    Pourebrahim R; Zhang Y; Liu B; Gao R; Xiong S; Lin PP; McArthur MJ; Ostrowski MC; Lozano G
    Genes Dev; 2017 Sep; 31(18):1847-1857. PubMed ID: 29021240
    [No Abstract]   [Full Text] [Related]  

  • 23. MicroRNA‑20a promotes the proliferation and cell cycle of human osteosarcoma cells by suppressing early growth response 2 expression.
    Zhuo W; Ge W; Meng G; Jia S; Zhou X; Liu J
    Mol Med Rep; 2015 Oct; 12(4):4989-94. PubMed ID: 26238942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical importance of S100A9 in osteosarcoma development and as a diagnostic marker and therapeutic target.
    Liu Y; Luo G; He D
    Bioengineered; 2019 Dec; 10(1):133-141. PubMed ID: 31055998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second messenger signaling in the regulation of cytosolic pH and DNA synthesis by parathyroid hormone (PTH) and PTH-related peptide in osteoblastic osteosarcoma cells: role of Na+/H+ exchange.
    Sugimoto T; Kano J; Fukase M; Fujita T
    J Cell Physiol; 1992 Jul; 152(1):28-34. PubMed ID: 1320038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
    Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
    PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA GClnc1 promotes tumorigenesis in osteosarcoma by inhibiting p53 signaling.
    Sui Y; Han Y; Zhao X; Li D; Li G
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):36-42. PubMed ID: 30454890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma.
    Yang R; Piperdi S; Zhang Y; Zhu Z; Neophytou N; Hoang BH; Mason G; Geller D; Dorfman H; Meyers PA; Healey JH; Phinney DG; Gorlick R
    Clin Orthop Relat Res; 2016 Jan; 474(1):178-89. PubMed ID: 26463566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptional regulation of tumor suppressor p53 by cAMP-responsive element-binding protein/AMP-activated protein kinase complex in response to glucose deprivation.
    Okoshi R; Ando K; Suenaga Y; Sang M; Kubo N; Kizaki H; Nakagawara A; Ozaki T
    Genes Cells; 2009 Dec; 14(12):1429-40. PubMed ID: 19930465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. siRNA targeting TCTP suppresses osteosarcoma cell growth and induces apoptosis in vitro and in vivo.
    Shen JH; Qu CB; Chu HK; Cui MY; Wang YL; Sun YX; Song YD; Li G; Shi FJ
    Biotechnol Appl Biochem; 2016; 63(1):5-14. PubMed ID: 25522670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long non-coding RNA SNHG1 regulates NOB1 expression by sponging miR-326 and promotes tumorigenesis in osteosarcoma.
    Wang J; Cao L; Wu J; Wang Q
    Int J Oncol; 2018 Jan; 52(1):77-88. PubMed ID: 29115574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling.
    Lengner CJ; Steinman HA; Gagnon J; Smith TW; Henderson JE; Kream BE; Stein GS; Lian JB; Jones SN
    J Cell Biol; 2006 Mar; 172(6):909-21. PubMed ID: 16533949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parathyroid hormone/parathyroid hormone-related peptide regulate osteosarcoma cell functions: Focus on the extracellular matrix (Review).
    Nikitovic D; Kavasi RM; Berdiaki A; Papachristou DJ; Tsiaoussis J; Spandidos DA; Tsatsakis AM; Tzanakakis GN
    Oncol Rep; 2016 Oct; 36(4):1787-92. PubMed ID: 27499459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA damage checkpoint pathway modulates the regulation of skeletal growth and osteoblastic bone formation by parathyroid hormone-related peptide.
    Zhang Y; Chen G; Gu Z; Sun H; Karaplis A; Goltzman D; Miao D
    Int J Biol Sci; 2018; 14(5):508-517. PubMed ID: 29805302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer.
    Johnson RW; Merkel AR; Page JM; Ruppender NS; Guelcher SA; Sterling JA
    Clin Exp Metastasis; 2014 Dec; 31(8):945-59. PubMed ID: 25359619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cooperation of CREB and NFAT is required for PTHrP-induced RANKL expression in mouse osteoblastic cells.
    Park HJ; Baek K; Baek JH; Kim HR
    J Cell Physiol; 2015 Mar; 230(3):667-79. PubMed ID: 25187507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parathyroid hormone-related peptide regulates matrix metalloproteinase-13 gene expression in bone metastatic breast cancer cells.
    Ibaragi S; Shimo T; Iwamoto M; Hassan NM; Kodama S; Isowa S; Sasaki A
    Anticancer Res; 2010 Dec; 30(12):5029-36. PubMed ID: 21187486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Notch activation as a driver of osteogenic sarcoma.
    Tao J; Jiang MM; Jiang L; Salvo JS; Zeng HC; Dawson B; Bertin TK; Rao PH; Chen R; Donehower LA; Gannon F; Lee BH
    Cancer Cell; 2014 Sep; 26(3):390-401. PubMed ID: 25203324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RASSF5 inhibits growth and invasion and induces apoptosis in osteosarcoma cells through activation of MST1/LATS1 signaling.
    Zhou XH; Yang CQ; Zhang CL; Gao Y; Yuan HB; Wang C
    Oncol Rep; 2014 Oct; 32(4):1505-12. PubMed ID: 25109282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knockdown of TNFAIP1 inhibits growth and induces apoptosis in osteosarcoma cells through inhibition of the nuclear factor-κB pathway.
    Zhang CL; Wang C; Yan WJ; Gao R; Li YH; Zhou XH
    Oncol Rep; 2014 Sep; 32(3):1149-55. PubMed ID: 24969828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.